Identification of Novel and Selective Cyclooxygenase 2 (COX-2) Inhibitors: Comprehensive In-Silico Investigations

Key Points

• Selective COX-2 inhibitors may enhance therapeutic options for inflammatory conditions.
• In-silico studies revealed potential candidates that could lead to novel drug development.
• This observational analysis explores computational methods to identify specific molecular targets.
• The findings imply possible advancements in anti-inflammatory therapies, though experimental validation is needed.